Announcements Trials
Browse Landscape

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Breast Neoplasms 700Neoplasms 621Prostatic Neoplasms 322Lung Neoplasms 314Colorectal Neoplasms 284Carcinoma, Non-Small-Cell Lung 260Pancreatic Neoplasms 181Carcinoma, Hepatocellular 171Stomach Neoplasms 141Multiple Myeloma 127Ovarian Neoplasms 123Melanoma 118Colonic Neoplasms 114Brain Neoplasms 111Hematologic Neoplasms 107Urinary Bladder Neoplasms 104Head and Neck Neoplasms 104Leukemia, Myeloid, Acute 102Esophageal Neoplasms 100Disease 100Uterine Cervical Neoplasms 91Liver Neoplasms 91Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Endometrial Neoplasms 79Carcinoma, Renal Cell 74Leukemia 65Recurrence 63

Interventions

Sentinel Lymph Node Biopsy 1Ovariectomy 1Hysterectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma × 1 year × Clear all
NCT04604613 2026-03-09

Prediction of Recurrence Among Low Risk Endometrial Cancer Patients

M.D. Anderson Cancer Center

Active not recruiting
518 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

NCT06689956 2026-02-19

Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study

Mayo Clinic

Recruiting
212 enrolled
Gynecologic

FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡